First Episealer® surgery planned in Saudi Arabia
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Saudi Arabia with the knee implant Episealer® has been scheduled.
“We are now offering the Episealer® technology to our customers in an additional geography, and we are pleased with having the first surgery in Saudi Arabia scheduled. First-class partnerships with our indirect partners are very important to us and we appreciate the support we have in Saudi Arabia”, says Pål Ryfors, CEO Episurf Medical.
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] => <p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt">About Episurf Medical</span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</em></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"></p>
[HtmlContact:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><strong><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">For more information, please contact:</span></strong></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt;">Pål Ryfors, CEO, Episurf Medical<br /></span><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">Tel:</span><span style="font-size: 10pt;">+46 (0) 709 62 36 69<br /></span><span style="font-size: 10pt;">Email: </span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></p>
[HtmlTitle:protected] => <h1 style="line-height:120%;"><span style="font-family:arial,helvetica,sans-serif"><strong>First Episealer® surgery planned in Saudi Arabia </strong></span></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Saudi Arabia with the knee implant Episealer® has been scheduled.
“We are now offering the Episealer® technology to our customers in an additional geography, and we are pleased with having the first surgery in Saudi Arabia scheduled. First-class partnerships with our indirect partners are very important to us and we appreciate the support we have in Saudi Arabia”, says Pål Ryfors, CEO Episurf Medical.
[HtmlBody:protected] => <p style="text-align:justify; margin-bottom:10px;margin-top:12px"><span><span><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:9pt"><span><span style="color:black">Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Saudi Arabia with the knee implant Episealer® has been scheduled. </span></span></span></span></span></span></p>
<p><span><em><span style="font-size:9pt"><span><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">“We are now offering the Episealer® technology to our customers in an additional geography, and we are pleased with having the first surgery in Saudi Arabia scheduled. </span></span></span></span></em><span style="font-size:9pt"><span><span style="font-family:arial,helvetica,sans-serif"><em>First-class partnerships with our indirect partners are very important to us and we appreciate the support we have in Saudi Arabia</em></span></span></span><em><span style="font-size:9pt"><span><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">”,</span></span></span></span></em><span style="font-size:9pt"><span><span style="font-family:arial,helvetica,sans-serif"> says Pål Ryfors, CEO Episurf Medical.</span></span></span></span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Twitter
[Name:protected] => Twitter
[Value:protected] => 9341
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => LinkedIn
[Name:protected] => LinkedIn
[Value:protected] => 12311
)
[2] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Facebook
[Name:protected] => Facebook
[Value:protected] => 14035
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] => About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
[Contact:protected] => For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Pål Ryfors
[3] => Episealer
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/3541446/1560761.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => First Episealer® surgery planned in Saudi Arabia
[Description:protected] => First Episealer® surgery planned in Saudi Arabia
[CreateDate:protected] => 2022-04-07T06:30:25.38Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 4232409
[EncryptedId:protected] => 8B00C024CC49B636
[IsRegulatory:protected] =>
[PublishDate:protected] => 2022-04-07T06:30:00Z
[LastChangeDate:protected] => 2022-04-07T06:30:25.363Z
[Title:protected] => First Episealer® surgery planned in Saudi Arabia
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/first-episealer--surgery-planned-in-saudi-arabia,c3541446
[LanguageVersions:protected] => Array
(
[0] => CisionBlockPro\Cision\LanguageVersion Object
(
[Code:protected] => sv
[ReleaseId:protected] => 4232407
)
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)